Breakout Ventures

Type

Venture Capital

Status

Active

Location

San Francisco, United States

Total investments

30

Average round size

25M

Portfolio companies

21

Rounds per year

3.75

Lead investments

2

Follow on index

0.30

Exits

2

Stages of investment
SeedEarly Stage Venture
Areas of investment
BiotechnologyMachine LearningHealth CareHealth DiagnosticsMedicalLife SciencePharmaceuticalTherapeuticsAdvanced MaterialsClinical Trials

Summary

Breakout Ventures is the famous VC, which was founded in 2016. The leading representative office of defined VC is situated in the San Francisco. The fund was located in North America if to be more exact in United States.

The typical case for the fund is to invest in rounds with 6 participants. Despite the Breakout Ventures, startups are often financed by Dolby Family Ventures, Lux Capital, Data Collective DCVC. The meaningful sponsors for the fund in investment in the same round are Dolby Family Ventures, Blackhorn Ventures, Western Technology Investment. In the next rounds fund is usually obtained by Dolby Family Ventures, Western Technology Investment, Vulcan Capital.

The common things for fund are deals in the range of 10 - 50 millions dollars. The typical startup value when the investment from Breakout Ventures is 10-50 millions dollars. The fund is generally included in 2-6 deals every year. Comparing to the other companies, this Breakout Ventures performs on 18 percentage points less the average number of lead investments. Speaking about the real fund results, this VC is 9 percentage points less often commits exit comparing to other organizations. The important activity for fund was in 2019. The increased amount of exits for fund were in 2019.

The fund has no exact preference in a number of founders of portfolio startups. If startup sums 1 or 5+ of the founder, the chance for it to be financed is low. Moreover, a startup needs to be at the age of 4-5 years to get the investment from the fund. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. Among the various public portfolio startups of the fund, we may underline Modern Meadow, Phylagen, Checkerspot Among the most successful fund investment fields, there are Pharmaceutical, Health Diagnostics.

We also calculated 3 valuable employees in our database.

Show more

Investor highlights

Industry focus
Deep TechBiotech/Life SciencesClimate techHealthcareMedtech
Stage focus
Seed

Discover reliable insights

Find relevant VC investors, identify key contacts and secure funding opportunities.

Investments analytics

Last fund

Fund size
USD 112500000
Fund raised date
2021-12-09

Analytics

Total investments
30
Lead investments
2
Exits
2
Rounds per year
3.75
Follow on index
0.30
Investments by industry
  • Biotechnology (19)
  • Life Science (11)
  • Therapeutics (6)
  • Medical (6)
  • Machine Learning (5)
  • Show 29 more
Investments by region
  • United States (28)
  • The Netherlands (1)
Peak activity year
2022

Discover reliable insights

Leverage validated data, identify key contacts and secure funding opportunities for your business.

Quantitative data

Avg. startup age at the time of investment
6
Avg. valuation at time of investment
714K
Group Appearance index
0.97
Avg. company exit year
8

Need more data?

Get access to full data about investors, including their team, contact information, and historic data.

Latest deals

Company name Deal date Industry Deal stage Deal size Location
17 Aug 2021 Financial Services, Trading Platform Seed 4M United States, New York, New York
Opus 12 08 Jul 2021 Chemical, Oil and Gas, Fuel, Environmental Consulting Early Stage Venture 57M United States, California, Berkeley
TFC Therapeutics 17 Aug 2023 Biotechnology, Medical, Biopharma Seed United States, New York, Nyack

Similar funds

By same location

By same geo focus

By doing lead investments

How we get our data

At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).

Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.